4.7 Article

Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. Report from the Art and Science of Endometriosis meeting

Journal

FERTILITY AND STERILITY
Volume 93, Issue 1, Pages 62-67

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2008.09.056

Keywords

Endometriosis; pain; quality of life; dysmenorrhea

Funding

  1. National Institute of Child Health and Human Development
  2. Ferring
  3. Neurocrine
  4. Pfizer
  5. Schering
  6. Takeda
  7. TAP Pharmaceuticals
  8. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008769, ZIEHD008737] Funding Source: NIH RePORTER
  9. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008769] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Standardized entry criteria and outcome measures for clinical trials in endometriosis-related pain would facilitate the comparison of trial results and the production of systematic reviews, improving evidence-based practice in this area. This report summarizes the recommendations from an international meeting for these criteria. (Fertil Steril(R) 2010;93:62-7. (C)2010 by American Society for Reproductive Medicine.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available